Charlotte Sumner

19PUBLICATIONS
98CO-AUTHORS
Neurology and neuromuscular diseasesInfant and child healthCraniofacial biologyFluid-structure interaction and aeroacousticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 23, 2026
Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

|Feb 03, 2026
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Richard S Finkel, Thomas O Crawford, Eugenio Mercuri

|Jun 30, 2025
Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy.

Florian Gerstner, Sandra Wittig, Christian Menedo

|Jun 27, 2025
The Progression of Infantile Spinal Muscular Atrophy: Why Gestational Age Matters.

Madeline Aldridge, Charlotte J Sumner

|May 14, 2025
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy.

Beltran Borges, Stephen M Brown, Wan-Jin Chen

|May 09, 2025
Charcot-Marie-Tooth disease type 1E: Clinical Natural History and Molecular Impact of PMP22 Variants.

Kailee S Ward, Christopher P Ptak, Natalya Pashkova

Pageof 4

Frequent Collaborators

4 joint publications

Brett A McCray

4 joint publications

Lingling Kong

3 joint publications

Richard S Finkel

3 joint publications

Thomas E Lloyd